Literature DB >> 15229376

The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus.

Rebecca S Tirabassi1, Joan F Flanagan, Tiangen Wu, Edward H Kislauskis, Paul J Birckbichler, Dennis L Guberski.   

Abstract

Congenic and inbred strains of rats offer researchers invaluable insight into the etiopathogenesis of diabetes and associated complications. The inbred Bio-Breeding Zucker diabetic rat (BBZDR)/Wor rat strain is a relatively new and emerging model of type 2 diabetes. This strain was created by classical breeding methods used to introgress the defective leptin receptor gene (Lepr(fa)) from insulin-resistant Zucker fatty rats into the inbred BBDR/Wor strain background. The diabetic male BBZDR/Wor rat is homozygous for the fatty mutation and shares the genetic background of the original BB strain. Although lean littermates are phenotypically normal, obese juvenile BBZDR/Wor rats are hyperlipidemic and hyperleptinemic, become insulin resistant, and ultimately develop hyperglycemia. Furthermore, the BBZDR/Wor rat is immune competent and does not develop autoimmunity. Similar to patients with clinical diabetes, the BBZDR/Wor rat develops complications associated with hyperglycemia. The BBZDR/Wor rat is a model system that fully encompasses the ability to study the complications that affect human type 2 diabetic patients. In this review, recent work that has evaluated type 2 diabetic complications in BBZDR/Wor rats is discussed, including the authors' preliminary unpublished studies on cardiovascular disease.

Entities:  

Mesh:

Year:  2004        PMID: 15229376     DOI: 10.1093/ilar.45.3.292

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  15 in total

1.  Differential effects of leptin receptor mutation on male and female BBDR Gimap5-/Gimap5- spontaneously diabetic rats.

Authors:  Daniel H Moralejo; Carl T Hansen; Piper Treuting; Martin J Hessner; Jessica M Fuller; Brian Van Yserloo; Richard Jensen; William Osborne; Anne E Kwitek; Ake Lernmark
Journal:  Physiol Genomics       Date:  2009-12-08       Impact factor: 3.107

Review 2.  Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab).

Authors:  G J Biessels; V Bril; N A Calcutt; N E Cameron; M A Cotter; R Dobrowsky; E L Feldman; P Fernyhough; J Jakobsen; R A Malik; A P Mizisin; P J Oates; I G Obrosova; R Pop-Busui; J W Russell; A A Sima; M J Stevens; R E Schmidt; S Tesfaye; A Veves; A I Vinik; D E Wright; S Yagihashi; M A Yorek; D Ziegler; D W Zochodne
Journal:  J Peripher Nerv Syst       Date:  2014-06       Impact factor: 3.494

Review 3.  Alternatives to the Streptozotocin-Diabetic Rodent.

Authors:  M A Yorek
Journal:  Int Rev Neurobiol       Date:  2016-03-28       Impact factor: 3.230

4.  Myogenic tone and reactivity of cerebral arteries in type II diabetic BBZDR/Wor rat.

Authors:  Yagna P R Jarajapu; Dennis L Guberski; Maria B Grant; Harm J Knot
Journal:  Eur J Pharmacol       Date:  2007-10-25       Impact factor: 4.432

Review 5.  New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism.

Authors:  Adrian Kee Keong Teo; Amy J Wagers; Rohit N Kulkarni
Journal:  Cell Metab       Date:  2013-09-12       Impact factor: 27.287

6.  Obesity associated pathophysiological & histological changes in WNIN obese mutant rats.

Authors:  Nemani Harishankar; Putcha Uday Kumar; Boindala Sesikeran; Nappanveettil Giridharan
Journal:  Indian J Med Res       Date:  2011-09       Impact factor: 2.375

Review 7.  Cutaneous innervation in impaired diabetic wound healing.

Authors:  Nicole C Nowak; Daniela M Menichella; Richard Miller; Amy S Paller
Journal:  Transl Res       Date:  2021-05-23       Impact factor: 10.171

8.  Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock.

Authors:  Julia V Busik; Maria Tikhonenko; Ashay Bhatwadekar; Madalina Opreanu; Nafissa Yakubova; Sergio Caballero; Danny Player; Takahiko Nakagawa; Aqeela Afzal; Jennifer Kielczewski; Andrew Sochacki; Stephanie Hasty; Sergio Li Calzi; Sungjin Kim; Shane K Duclas; Mark S Segal; Dennis L Guberski; Walter J Esselman; Michael E Boulton; Maria B Grant
Journal:  J Exp Med       Date:  2009-11-23       Impact factor: 14.307

9.  N-3 polyunsaturated Fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function.

Authors:  Maria Tikhonenko; Todd A Lydic; Madalina Opreanu; Sergio Li Calzi; Svetlana Bozack; Kelly M McSorley; Andrew L Sochacki; Matthew S Faber; Sugata Hazra; Shane Duclos; Dennis Guberski; Gavin E Reid; Maria B Grant; Julia V Busik
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

10.  Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts.

Authors:  Qing Li; Yuying C Hwang; Radha Ananthakrishnan; Peter J Oates; Dennis Guberski; Ravichandran Ramasamy
Journal:  Cardiovasc Diabetol       Date:  2008-10-28       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.